Status:
COMPLETED
The Longitudinal PTH-Study
Lead Sponsor:
Medical University of Vienna
Conditions:
CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Secondary Hyperparathyroidism
Eligibility:
All Genders
18+ years
Brief Summary
The main study aim is to quantify the agreement between the analytical results provided by two third generation and two second generation Parathyroid hormone (PTH) assays. The primary comparison will ...
Eligibility Criteria
Inclusion
- All patients who were undergoing uninterrupted hemodialysis or hemodiafiltration at the Chronic Hemodialysis Unit of the Division of Nephrology and Dialysis, Medical University of Vienna between November 1st, 2017 and December 31st, 2018.
- Existence of residual blood samples from four successive quarterly routine controls
- Age ≥ 18 years
- The test result of the assay must not have any diagnostic value or therapeutic consequence for the patients included in this study.
Exclusion
- Death during the observational period (all patients must have lived through the 1-year period and must have all 4 quarterly blood draws performed on them).
- Age \<18 years
Key Trial Info
Start Date :
March 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 7 2019
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT03464149
Start Date
March 20 2018
End Date
August 7 2019
Last Update
June 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria
Vienna, Austria, 1090